In vitro skin irritation testing has emerged as a critical component in the safety evaluation of chemicals and medical devices, aiming to replace traditional animal-based assays. Central to this ...

In a recent study posted to the bioRxiv* preprint server, researchers developed a novel in vitro model that expresses the angiotensin-converting enzyme 2 (ACE-2) receptor from seven bar species in a ...

The World Health Organization (WHO) has listed the first mpox in vitro diagnostic (IVD) under its Emergency Use Listing (EUL) procedure, an important step in improving global access to mpox testing.

Although several countries—and even some U.S. states—are beginning to create laws that ban or limit the practice of animal testing for cosmetics, the sad reality is that some companies continue to ...

Please provide your email address to receive an email when new articles are posted on . The FDA granted breakthrough device designation and permitted marketing for the first in vitro diagnostic test ...

FOR BIOTECH, DEB, IT REALLY IS. IN THE PAST LEGISLATIVE SESSION, MARYLAND’S GENERAL ASSEMBLY PASSED A BILL PROVIDING GRANTS TO MARYLAND SCIENTISTS WHO DEVELOP NON ANIMAL BASED RESEARCH METHODS. IT WAS ...

The Food and Drug Administration has approved marketing for the first in vitro diagnostic test for early detection of Alzheimer’s disease. FDA PUTS NEW LIMITS ON JOHNSON & JOHNSON VACCINE DUE TO RARE ...

Association of a Lay Health Worker–Led Intervention on Goals of Care, Quality of Life, and Clinical Trial Participation Among Low-Income and Minority Adults With Cancer We used a simplified version of ...

The test leads people undergoing in vitro fertilization to discard thousands of embryos each year. The new research found implanting some “abnormal” embryos resulted in healthy live births. By Azeen ...

The FDA cleared its first in vitro test to help determine whether people showing signs of cognitive decline also carry one of the hidden hallmarks of Alzheimer’s disease. The diagnostic detects ...

Recent advances in immunotherapy, targeted therapies, and gene therapies have significantly improved survival rates for patients with cancer. However, over time, many tumours develop resistance to ...